Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Kyfil 30mg Injection

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Carfilzomib (30mg)

Overview Kyfil 30mg Injection

Myeloma treatment utilizes Kyfil 30mg Injection, which inhibits or retards cancerous cell proliferation. Administered intravenously by a healthcare professional, dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose risks severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Common side effects include tiredness, queasiness, and elevated temperature. Kyfil 30mg Injection can lower blood cell counts (red and white), raising infection risk. Report fever, chills, musculoskeletal pain, facial flushing/edema, or chest discomfort to your doctor promptly. Maintain adequate hydration during treatment. Prior to commencing therapy, disclose any existing heart, liver, or kidney ailments, or concurrent use of antimicrobial medications. Drug interactions are possible; inform your healthcare provider of all medications you are taking. Pregnancy and breastfeeding are contraindications; reliable contraception is essential for both partners throughout treatment.

Primary Ingredients of Kyfil 30mg Injection

No text provided. Please provide the text you would like me to rephrase.

Uses of Kyfil 30mg Injection

Plasma cell malignancy

Major Benefits of Kyfil 30mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Kyfil 30mg Injection:

  • Fatigue
  • Anemia (low number of red blood cells)
  • Nausea
  • Low blood platelets
  • Fever

How to use Kyfil 30mg Injection:

Administering this medication will be performed by your healthcare provider. Self-medication is strictly prohibited.

How Kyfil 30mg Injection works:

Kyfil 30mg Injection is an anticancer agent that inhibits protein degradation within cancerous cells. This accumulation of proteins subsequently triggers apoptosis in these cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Kyfil 30mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Kyfil 30mg Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in rare, life-threatening circumstances where the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingUNSAFE

Administration of Kyfil 30mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harmful effects to the nursing infant.

DrivingDrivingUNSAFE

Administering Kyfil 30mg Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Patients with kidney impairment should use Kyfil 30mg Injection cautiously, as dose modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

The administration of Kyfil 30mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification of Kyfil 30mg Injection might be necessary. Physician consultation is advised.

What if you forget to take Kyfil 30mg Injection :

NA

Facts to Know About Kyfil 30mg Injection

LabelValue
Chemical Category Epoxomicin Analog
Developing Habits No.
Treatment Category Cancer Medications
Actions Proteasome inhibitor therapy

FAQs on Kyfil 30mg Injection

Kyfil 30mg Injection, used with other drugs, treats relapsed or refractory multiple myeloma. Consult your doctor if you have questions.
Kyfil 30mg Injection is administered intravenously (IV) via infusion, delivering medication directly into the bloodstream.
This injection is administered in four-week treatment cycles. Each cycle involves treatment on certain days and rest periods. Typically, you'll receive Kyfil 30mg Injection twice weekly for three weeks, followed by a treatment-free week. Your doctor will personalize your treatment plan.
This medication may cause nausea and fatigue. To alleviate nausea, try eating smaller, more frequent meals and avoid rich, spicy, or greasy foods. Combat fatigue with adequate rest and gentle daily exercise.
This medication may lower your platelet count, increasing your risk of infection. To minimize this risk, avoid crowded places and people with illnesses. Practice frequent handwashing, especially after using the restroom.
Seek immediate medical attention if you experience shortness of breath, prolonged or excessive bleeding, jaundice (yellowing of skin and eyes), severe headache, confusion, seizures, or vision loss.
Kyfil 30mg Injection may harm an unborn baby if administered to a pregnant woman. Effective contraception should be used by women throughout treatment and for six months afterward. Men should also use effective contraception during and for three months after treatment.
This medication may transfer to breast milk, potentially harming your baby. Avoid breastfeeding throughout treatment and for two weeks following your last dose.
Kyfil 30mg Injection may cause dehydration; drink plenty of fluids. Dizziness is a possible side effect; avoid driving or operating machinery. To prevent rashes, limit sun exposure and use SPF 15+ sunscreen and protective clothing.
Kyfil 30mg Injection
5,875
MRP 6,800
13% off